Janssen’s Remicade is the third biggest pharmaceutical brand globally with sales exceeding $8 billion last year.

Pharma major Ranbaxy Laboratories today reported a drastic drop in net loss at Rs 158.48 crore during the fourth quarter ended December 31,...

Ranbaxy Laboratories have entered into a licensing pact with EPIRUS Switzerland GmbH for treating rheumatoid arthiritis.

The best workplaces have redefined their agenda by improving employee positive perceptions about work life balance by a phenomenal 18% in t...